ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Neurology

Top Neurology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LEONID BOUINYI M.D.

Neurology

1,138

$243K

142
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$213
Average prescription price

Avg: $206

SOPHOS GEROULIS M.D.

Neurology

1,129

$277K

174
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$246
Average prescription price

Avg: $206

MICHAEL SNYDER MD

Neurology

1,126

$162K

179
117 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$144
Average prescription price

Avg: $206

BARRY PASSINI MD

Neurology

1,124

$257K

161
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$229
Average prescription price

Avg: $206

VERICA NESKOVIC MD

Neurology

1,124

$246K

171
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$219
Average prescription price

Avg: $206

MARK SZMANDA MD

Neurology

1,093

$161K

144
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 22%

$148
Average prescription price

Avg: $206

AJAZ QHAVI MD

Neurology

1,089

$89.7K

141
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $206

DANIEL SA MD

Neurology

1,065

$190K

169
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$179
Average prescription price

Avg: $206

ROBERT GOLDMAN MD

Neurology

1,014

$233K

155
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 22%

$230
Average prescription price

Avg: $206

JON KONZEN

Neurology

1,011

$144K

106
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$143
Average prescription price

Avg: $206

GENEVIEVE JONES M.D.

Neurology

975

$209K

107
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$214
Average prescription price

Avg: $206

DOUGLAS DULLI MD MS

Neurology

968

$46.7K

115
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

10%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $206

ALEXANDRU BARBOI MD

Neurology

963

$143K

136
65 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$148
Average prescription price

Avg: $206

ALEXANDER SPITZER MD

Neurology

945

$226K

151
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$239
Average prescription price

Avg: $206

WALTER WONG MD

Neurology

937

$119K

111
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$127
Average prescription price

Avg: $206

KATIE SPANGLER M.D.

Neurology

933

$105K

126
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 22%

$113
Average prescription price

Avg: $206

CHRISTOPHER ANDERSON MD

Neurology

929

$196K

81
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 22%

$211
Average prescription price

Avg: $206

MAMOUN KLOUB MD, PHD

Neurology

918

$128K

129
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 22%

$139
Average prescription price

Avg: $206

PAT BRYANT MD

Neurology

912

$80.5K

122
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$88
Average prescription price

Avg: $206

GURDESH BEDI MD

Neurology

911

$166K

167
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$182
Average prescription price

Avg: $206

DEBASISH BHATTACHARYYA MD

Neurology

907

$83.4K

170
107 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $206

ROBERT JONES M.D.

Neurology

904

$108K

158
95 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 22%

$119
Average prescription price

Avg: $206

BENJAMIN LAWLER MD

Neurology

902

$111K

178
113 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$123
Average prescription price

Avg: $206

PIERO ANTUONO MD

Neurology

890

$168K

107
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

50%
prescriptions for brand name drugs

Avg: 22%

$189
Average prescription price

Avg: $206

CELESTE CASE MD

Neurology

888

$124K

125
66 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$140
Average prescription price

Avg: $206

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank